Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
---|
07/29/2010 | US20100187515 Use of a Precursor of an N-Dopant for Doping an Organic Semiconductive Material, Precursor and Electronic or Optoelectronic Component |
07/29/2010 | CA2750777A1 Bicyclic heterocyclic spiro compounds |
07/29/2010 | CA2750106A1 Poly (adp-ribose) polymerase (parp) inhibitors |
07/29/2010 | CA2749807A1 A method for determination of sirolimus stability and process for preparing its stable form |
07/29/2010 | CA2749217A1 Compositions and methods for inhibition of the jak pathway |
07/28/2010 | EP2210893A1 Polymorphous forms of rifaximin as antibiotics |
07/28/2010 | EP2209790A2 Equilibrative nucleoside transporter ent1 inhibitors |
07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
07/28/2010 | EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
07/27/2010 | US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
07/27/2010 | US7763734 Synthesis, structure and use of bisoxazolidines for asymmetric catalysis and synthesis |
07/27/2010 | US7763606 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases |
07/27/2010 | CA2463084C Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
07/27/2010 | CA2457034C Ophthalmic composition comprising an ascomycin |
07/22/2010 | WO2010082050A1 Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections |
07/22/2010 | WO2010081877A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
07/22/2010 | WO2010081488A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
07/22/2010 | US20100184992 Stable neutral nitric oxide source |
07/22/2010 | US20100184755 Protein kinase c inhibitors and uses thereof |
07/21/2010 | EP2208730A1 Polymorphic forms of rifaximin, processes for their production and use thereof in medicinal preparations |
07/21/2010 | EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
07/21/2010 | CN101784553A 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
07/21/2010 | CN101781314A Preparation process of levofloxacin hemihydrate |
07/21/2010 | CN101781313A Method for synthesizing quinolone medicaments |
07/20/2010 | US7759340 Antibacterial agents |
07/20/2010 | US7759337 N-cyclopropyl-4-methyl-3-{1-[(2R)-2-methylpiperazin-1-yl]phthalazin-6-yl}benzamide, useful for the prophylaxis and treatment of protein kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders |
07/15/2010 | WO2010057101A3 Compounds useful as hiv blockers |
07/15/2010 | US20100179318 Process to make lestaurtinib |
07/15/2010 | US20100179190 Bicyclic pyrazolo protein kinase modulators |
07/15/2010 | US20100179135 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
07/15/2010 | US20100178294 Macrocyclic beta-secretase inhibitors |
07/14/2010 | EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor |
07/14/2010 | EP2205599A1 Cgrp antagonists |
07/14/2010 | EP1991223B1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
07/14/2010 | EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
07/14/2010 | EP1551849B1 Tricyclic tetrahydroquinoline antibacterial agents |
07/14/2010 | CN101775026A Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof |
07/13/2010 | US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
07/13/2010 | CA2567776C Vasopressin v1a antagonists |
07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
07/08/2010 | WO2010076418A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same |
07/08/2010 | WO2010056633A3 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
07/08/2010 | US20100174064 Forms of rifaximin and uses thereof |
07/08/2010 | US20100173913 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents |
07/08/2010 | US20100173902 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
07/08/2010 | US20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease |
07/08/2010 | CA2745503A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same |
07/07/2010 | EP2203459A1 Spirocyclic aminoquinolones as gsk-3 inhibitors |
07/07/2010 | EP2203458A2 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
07/07/2010 | CN101772504A substituted bicyclolactam compounds |
07/07/2010 | CN101772493A gamma secretase modulators |
07/07/2010 | CN101768173A Norcantharidin dimer derivate as well as synthetic method and application thereof |
07/07/2010 | CN101768167A Method for synthesizing piperazine of levofloxacin |
07/06/2010 | US7749997 Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
07/06/2010 | US7749994 serine/threonine kinase inhibitors, useful for therapy and/or prophylaxis of cancers in mammals |
07/01/2010 | WO2010075273A1 Bicyclic heterocycle derivatives and methods of use thereof |
07/01/2010 | WO2010075204A2 Gamma secretase modulators |
07/01/2010 | WO2010075203A1 Gamma secretase modulators |
07/01/2010 | WO2010073034A1 Pyrimidine indole derivatives for treating cancer |
07/01/2010 | WO2010036921A3 Slow release of organoboronic acids in cross-coupling reactions |
07/01/2010 | US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders |
07/01/2010 | US20100168095 Multi-cyclic cinnamide derivatives |
07/01/2010 | US20100168093 Substituted 3-amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments |
07/01/2010 | US20100168091 Imidazole Amines As Inhibitors Of Beta-secretase |
07/01/2010 | US20100168080 Novel compounds useful as cc chemokine receptor ligands |
07/01/2010 | US20100163813 Long wavelength shifted benzotriazole uv-absorbers and their use |
07/01/2010 | CA2772760A1 Small molecule inhibitors of necroptosis |
07/01/2010 | CA2750841A1 Pyrimidine indole derivatives for treating cancer |
07/01/2010 | CA2747750A1 Gamma secretase modulators |
07/01/2010 | CA2747744A1 Gamma secretase modulators |
06/30/2010 | EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds |
06/30/2010 | CN101759707A Heterocyclic ring substituent norcantharidin derivative and synthesis method and application thereof |
06/30/2010 | CN101759645A P38 inhibitors and methods of use thereof |
06/29/2010 | US7745457 Meridamycin analogues for the treatment of neurodegenerative disorders |
06/24/2010 | WO2010071819A1 Bicyclic heterocyclic derivatives and methods of use thereof |
06/24/2010 | WO2010071211A1 Cyclic carbodiimide compounds |
06/24/2010 | WO2010070022A1 Novel compounds |
06/24/2010 | WO2010069850A1 Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer |
06/24/2010 | US20100160626 Process For The Preparation Of 3,7-Dihydroxy-1,5-Diazacyclooctanes |
06/24/2010 | US20100160403 Hcv ns3 protease inhibitors |
06/24/2010 | US20100160330 Novel bicyclic heterocycles useful as selective androgen receptor modulators |
06/24/2010 | US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore |
06/24/2010 | US20100160310 2,4 (4,6) pyrimidine derivatives |
06/24/2010 | US20100160255 Spiro-cyclic compound |
06/24/2010 | CA2746982A1 Cyclic carbodiimide compound |
06/24/2010 | CA2744935A1 New compounds |
06/23/2010 | EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
06/23/2010 | EP2198858A1 Sustained release preparation of a macrolide compound like tacrolimus |
06/23/2010 | EP2197884A2 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
06/23/2010 | CN101747320A Dialdehyde-built disinsection activity-having nitrogen or oxygen-containing heterocyclic compound and preparation method |
06/22/2010 | US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
06/22/2010 | US7741339 Fab I inhibitors |
06/22/2010 | US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation |
06/22/2010 | US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines |
06/22/2010 | US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
06/22/2010 | US7741325 Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds |
06/22/2010 | CA2444198C Nociceptin analogs |
06/22/2010 | CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient |
06/17/2010 | WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |